Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 147

Sort by

Sort Order Select

Journal Articles

GSDME-mediated pyroptosis contributes to chemotherapy-induced platelet hyperactivity and thrombotic potential

Ruyi Xue, Min Li, Ge Zhang, Wei Zhang, Liping Han, Tao Bo, Haoxuan Zhong, Dingjin Yao, Yiran Deng, She Chen, Si Zhang

Blood (2024) 144 (25): 2652–2665.

https://doi.org/10.1182/blood.2023023179

Published: 2024

Includes: Supplemental data

Journal Articles

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

Zhangyuting He, Huiying Zhu, Chong Wei, Danqing Zhao, Wei Wang, Jian Li, Wei Zhang, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6504.

https://doi.org/10.1182/blood-2024-203008

Published: 2024

Journal Articles

Symptom Burden and Health-Related Quality of Life in Patients with Aggressive Non-Hodgkin Lymphoma in China: A Cross-Sectional Study

Jiayue Jin, Simeng Ren, Wei Zhang, Ping Yang, Jingqi Yang, Hongkun Xu, Baojin Han, Wenzheng Zhang, Jie - Liu

Blood (2024) 144 (Supplement 1): 6437.

https://doi.org/10.1182/blood-2024-194707

Published: 2024

Journal Articles

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

Chao Chen, Jingjing Yin, Minghui Duan, Chong Wei, Congwei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6400.

https://doi.org/10.1182/blood-2024-203578

Published: 2024

Journal Articles

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

Chao Chen, Jingjing Yin, Wei Wang, Danqing Zhao, Chong Wei, Cong-Wei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6395.

https://doi.org/10.1182/blood-2024-202966

Published: 2024

Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Study

Blood (2024) 144 (Supplement 1): 4450.

https://doi.org/10.1182/blood-2024-209224

Published: 2024

Journal Articles

Analysis of Anxiety and Depression Status and Influencing Factors in Multiple Myeloma Patients

Mengran Gao, Wei Zhang, Rong Fu

Blood (2024) 144 (Supplement 1): 7880.

https://doi.org/10.1182/blood-2024-210353

Published: 2024

Journal Articles

TGF-β Pathway Inhibition Improves Hematopoietic Deficiency and Immune Imbalance By Repairing Endothelial Progenitor Cell Function in Aplastic Anemia

Xinyan Zhang, Li-Ping Guo, Jin-Song Jia, Ya-Zhe Wang, Mi Liang, Mengzhu Shen, Zhenkun Wang, Chen-Yuan Li, Zhong-Shi Lyu, Tong Xing, Zhi-Wei Zhang, Yuan-Yuan Zhang, Xiao-Jun Huang, Yuan Kong

Blood (2024) 144 (Supplement 1): 4074.

https://doi.org/10.1182/blood-2024-201438

Published: 2024

Journal Articles

BMS-986458 a Potential First-in-Class, Highly Selective, Potent and Well Tolerated BCL6 Ligand Directed Degrader (LDD) Demonstrates Multi-Modal Anti-Tumor Efficacy for the Treatment of B-Cell Non-Hodgkin's Lymphoma

Blood (2024) 144 (Supplement 1): 957.

https://doi.org/10.1182/blood-2024-210951

Published: 2024

Journal Articles

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Huiying Zhu, Danqing Zhao, Zhe Zhuang, Chao Chen, Wei Zhang, Daobin Zhou, Jian Li, Yan Zhang

Blood (2024) 144 (Supplement 1): 7148.

https://doi.org/10.1182/blood-2024-207024

Published: 2024

Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Gemcitabine, Cisplatin and Dexamethasone in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma: A Phase I Study

Chong Wei, Shengyu Zhou, Shuangnian Xu, Hongmei Jing, Hui Liu, Wei Zhang, Daobin Zhou

Blood (2024) 144 (Supplement 1): 1691.

https://doi.org/10.1182/blood-2024-209576

Published: 2024

Journal Articles

Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy

Zhenkun Wang, Zhi-Wei Zhang, Zhong-Shi Lyu, Tong Xing, Mi Liang, Mengzhu Shen, Chen-Yuan Li, Xin-Yan Zhang, Dan-Dan Chen, Ya-Zhe Wang, Li-Juan Hu, Hao Jiang, Qian Jiang, Yuan Kong, Xiao-Jun Huang

Blood (2024) 144 (Supplement 1): 2684.

https://doi.org/10.1182/blood-2024-201354

Published: 2024

Journal Articles

Identifying 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA and Treatment Response in Multiple Myeloma with a Multi-Step Machine Learning Approach

Bei Wang, Benjamin A Derman, Zhou Zhang, Krissana Kowitwanich, John F. Cursio, Daniel Appelbaum, Chuan He, Wei Zhang, Andrzej J Jakubowiak, Brian Chiu

Blood (2024) 144 (Supplement 1): 3336.

https://doi.org/10.1182/blood-2024-204305

Published: 2024

Journal Articles

Development of a Same-Day Closed CAR-T Cell Manufacturing Process to Generate Lentivector Loaded Lymphocytes Ready for Subcutaneous Injection

Sid Kerkar, Lintao Liu, Michael Betts, Liang Li, Michelle Andraza, Ewa Jaruga-Killeen, Cody Gowan, Ting Han, Jia Shi, Rang Gao, Suraj Kachgal, Gregory Wade, Wei Zhang, Gregory Frost

Blood (2023) 142 (Supplement 1): 6812.

https://doi.org/10.1182/blood-2023-189117

Published: 2023

Journal Articles

Extrachromosomal Circular DNA Drives the Progression of DLBCL through Activating the Sting Pathway

Zijuan Wu, Wei Zhang, Luqiao Wang, Lei Fan, Jianyong Li, Hui Jin

Blood (2023) 142 (Supplement 1): 1628.

https://doi.org/10.1182/blood-2023-190771

Published: 2023

Journal Articles

Analysis of Influencing Factors of Positive Antiplatelet Antibody in Patients with Diffuse Large B-Cell Lymphoma

Wei Zhang, Longrong Ran, Mingyu Zhao, Yu Peng, Xin Luo, Shuang Chen, Zailin Yang, Yao Liu

Blood (2023) 142 (Supplement 1): 6300.

https://doi.org/10.1182/blood-2023-182666

Published: 2023

Journal Articles

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

Blood (2023) 142 (Supplement 1): 6140.

https://doi.org/10.1182/blood-2023-180373

Published: 2023

Journal Articles

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 3048.

https://doi.org/10.1182/blood-2023-182812

Published: 2023

Journal Articles

Results of a Second, Prespecified Analysis of the Phase 2 Study ELM-2 Confirm High Rates of Durable Complete Response with Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) with Extended Follow-up

Blood (2023) 142 (Supplement 1): 3041.

https://doi.org/10.1182/blood-2023-181650

Published: 2023

Journal Articles

Maintenance of Moderate to High Levels of Functioning and Quality of Life with Odronextamab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 669.

https://doi.org/10.1182/blood-2023-181942

Published: 2023

NARROW

GSDME-mediated pyroptosis contributes to chemotherapy-induced platelet hyperactivity and thrombotic potential

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

Symptom Burden and Health-Related Quality of Life in Patients with Aggressive Non-Hodgkin Lymphoma in China: A Cross-Sectional Study

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Study

Analysis of Anxiety and Depression Status and Influencing Factors in Multiple Myeloma Patients

TGF-β Pathway Inhibition Improves Hematopoietic Deficiency and Immune Imbalance By Repairing Endothelial Progenitor Cell Function in Aplastic Anemia

BMS-986458 a Potential First-in-Class, Highly Selective, Potent and Well Tolerated BCL6 Ligand Directed Degrader (LDD) Demonstrates Multi-Modal Anti-Tumor Efficacy for the Treatment of B-Cell Non-Hodgkin's Lymphoma

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Combination of Mitoxantrone Hydrochloride Liposome with Gemcitabine, Cisplatin and Dexamethasone in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma: A Phase I Study

Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy

Identifying 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA and Treatment Response in Multiple Myeloma with a Multi-Step Machine Learning Approach

Development of a Same-Day Closed CAR-T Cell Manufacturing Process to Generate Lentivector Loaded Lymphocytes Ready for Subcutaneous Injection

Extrachromosomal Circular DNA Drives the Progression of DLBCL through Activating the Sting Pathway

Analysis of Influencing Factors of Positive Antiplatelet Antibody in Patients with Diffuse Large B-Cell Lymphoma

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Results of a Second, Prespecified Analysis of the Phase 2 Study ELM-2 Confirm High Rates of Durable Complete Response with Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) with Extended Follow-up

Maintenance of Moderate to High Levels of Functioning and Quality of Life with Odronextamab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only